0

60 MG HEPCDAC Tablet

60 MG HEPCDAC Tablet
60 MG HEPCDAC Tablet
Product Description
60 MG HEPCDAC Tablet is the one indicated for use with sofosbuvir for the treatment of patients with chronic HCV genotype 3 infection in adults. Sustained virologic response (SVR) rates are reduced in HCV genotype 3-infected patients with cirrhosis receiving 60 MG HEPCDAC Tablet in combination with sofosbuvir for 12 weeks.

Contact Us

B No. S-3, Purnima Apartment, Vidyanagar Main Road, Rajkot, Gujarat, 360001, India
Phone :91-281-2483449